Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02524769 · ClinicalTrials.gov registry record · NA
The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides
A NA study, sponsored by Loyola University.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT02524769 is a NA study that has completed, run by Loyola University. The registered enrollment target is 27 participants.
The verdict
NCT02524769, a NA study, has completed, sponsored by Loyola University.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The medical field is beginning to adopt treatments that alter an individual's microbiome to improve patient health; however, this approach has not been adopted for treatment of lower urinary tract symptoms (LUTS). Here, the investigators propose the first step in development of such a therapy. If the investigators hypothesis is correct, the investigators could change the first line of treatment for hypoestrogenic women and develop future therapies that modulate bacteria in the bladder to improve not only LUTS but also treatment response. This could lead to the first treatment for lower urinary disorders that incorporates a person's individual microbiome.
Interventions
- DRUG conjugated estrogen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02524769
The ClinicalTrials.gov registry entry for NCT02524769 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which conjugated estrogen is the first listed.
NCT02524769 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02524769 about?
NCT02524769 is a clinical study titled "The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides". The medical field is beginning to adopt treatments that alter an individual's microbiome to improve patient health; however, this approach has not been adopted for treatment of lower urinary tract symptoms (LUTS). Here, the investigators propose the first step in development of such a therapy. If th...
What is the current status of trial NCT02524769?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2015-12. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02524769?
The interventions under investigation include: conjugated estrogen (DRUG).
Who is sponsoring clinical trial NCT02524769?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.